<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html xmlns:v="urn:schemas-microsoft-com:vml"
  xmlns:o="urn:schemas-microsoft-com:office:office"
  xmlns:w="urn:schemas-microsoft-com:office:word"
  xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
  xmlns:mv="http://macVmlSchemaUri"
  xmlns="http://www.w3.org/TR/REC-html40">
  <head>
    <meta name="Title" content="APE">
    <meta name="Keywords" content="">
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <meta name="ProgId" content="Word.Document">
    <meta name="Generator" content="Microsoft Word 14">
    <meta name="Originator" content="Microsoft Word 14">
    <link rel="File-List" href="7endocrino_archivos/filelist.xml">
    <title>APE</title>
    <!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Santi Ibañez Caturla</o:Author>
  <o:LastAuthor>Santi Ibañez Caturla</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>3392</o:TotalTime>
  <o:LastPrinted>2013-06-23T14:54:00Z</o:LastPrinted>
  <o:Created>2014-01-31T16:11:00Z</o:Created>
  <o:LastSaved>2014-01-31T18:11:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>2695</o:Words>
  <o:Characters>14824</o:Characters>
  <o:Lines>123</o:Lines>
  <o:Paragraphs>34</o:Paragraphs>
  <o:CharactersWithSpaces>17485</o:CharactersWithSpaces>
  <o:Version>14.0</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
    <link rel="themeData" href="7endocrino_archivos/themedata.xml">
    <!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>ES-TRAD</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="276">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
    <style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Courier New";
	panose-1:2 7 3 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:"MS Mincho";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 1 Car";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:0pt;
	font-weight:normal;}
h2
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 2 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:13.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-weight:normal;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 3 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;
	font-weight:normal;}
h4
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 4 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-weight:normal;
	font-style:italic;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Encabezado Car";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 212.6pt right 425.2pt;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Pie de p\00E1gina Car";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 212.6pt right 425.2pt;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3, li.MsoList3, div.MsoList3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4, li.MsoList4, div.MsoList4
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto de cuerpo Car";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
a:link, span.MsoHyperlink
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.Ttulo1Car
	{mso-style-name:"T\00EDtulo 1 Car";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 1";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo2Car
	{mso-style-name:"T\00EDtulo 2 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 2";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo3Car
	{mso-style-name:"T\00EDtulo 3 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 3";
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;}
span.Ttulo4Car
	{mso-style-name:"T\00EDtulo 4 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 4";
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-style:italic;}
span.EncabezadoCar
	{mso-style-name:"Encabezado Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Encabezado;}
span.PiedepginaCar
	{mso-style-name:"Pie de p\00E1gina Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Pie de p\00E1gina";}
span.TextodecuerpoCar
	{mso-style-name:"Texto de cuerpo Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto de cuerpo";}
span.apple-converted-space
	{mso-style-name:apple-converted-space;
	mso-style-unhide:no;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@page WordSection1
	{size:595.0pt 842.0pt;
	margin:36.0pt 36.0pt 36.0pt 36.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:12.3pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
@list l0
	{mso-list-id:202789493;
	mso-list-type:hybrid;
	mso-list-template-ids:1416144070 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:226041271;
	mso-list-type:hybrid;
	mso-list-template-ids:1604381164 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:235480126;
	mso-list-type:hybrid;
	mso-list-template-ids:1272054964 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:295261776;
	mso-list-type:hybrid;
	mso-list-template-ids:-477212652 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:480775170;
	mso-list-type:hybrid;
	mso-list-template-ids:-871840180 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:572594075;
	mso-list-type:hybrid;
	mso-list-template-ids:361500182 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6
	{mso-list-id:639000924;
	mso-list-type:hybrid;
	mso-list-template-ids:-2140401528 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7
	{mso-list-id:845633606;
	mso-list-type:hybrid;
	mso-list-template-ids:-1571882896 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:878662725;
	mso-list-type:hybrid;
	mso-list-template-ids:424701584 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l8:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l8:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l8:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l8:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l9
	{mso-list-id:1040399607;
	mso-list-type:hybrid;
	mso-list-template-ids:1007332440 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10
	{mso-list-id:1054236720;
	mso-list-type:hybrid;
	mso-list-template-ids:-774610160 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11
	{mso-list-id:1201823969;
	mso-list-type:hybrid;
	mso-list-template-ids:-1689888288 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12
	{mso-list-id:1387532721;
	mso-list-type:hybrid;
	mso-list-template-ids:-2105479504 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l12:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:1682660849;
	mso-list-type:hybrid;
	mso-list-template-ids:1556518110 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14
	{mso-list-id:1816024000;
	mso-list-type:hybrid;
	mso-list-template-ids:-1950839336 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l15
	{mso-list-id:1881089785;
	mso-list-type:hybrid;
	mso-list-template-ids:-769523296 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16
	{mso-list-id:1937866530;
	mso-list-type:hybrid;
	mso-list-template-ids:190511004 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style><!--[if gte mso 10]>
<style>
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Tabla normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
table.MsoTableGrid
	{mso-style-name:"Tabla con cuadr\00EDcula";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
  </head>
  <body style="tab-interval:35.4pt" vlink="purple" link="blue"
    lang="ES-TRAD">
    <div class="WordSection1">
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 27<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">ANOMALÍAS
            CONGÉNITAS DEL
            TIROIDES<o:p></o:p></span></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l14 level1 lfo2"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>AGENESIA TIROIDEA</u>:
        ausencia de tiroides
        por falta de formación.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l14 level1 lfo2"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>QUISTE DEL CONDUCTO
          TIROGLOSO</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo2"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Tumor
quístico
        de la línea anterior del cuello. Al pincharlo, contiene un
        liquido
        mucoide (color parado oscuro). Pasado el tiempo vuelve a
        rellenarse (recidiva),
        por lo que es necesaria la extirpación quirúrgica.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo2"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Etiología:
persistencia
        de restos del conducto tirogloso (forma un quiste por secreción
        de
        las células epiteliales, normalmente a la altura del hioides).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo2"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Es
una
        cavidad revestida de epitelio (quiste); por fuera puede haber
        folículos
        tiroideos.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l14 level1 lfo2"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>TIROIDES ECTÓPICO</u>:
        tejido tiroideo fuera
        de la glándula tiroides (en la glándula, en la zona de la V
        lingual o en el
        trayecto del conducto tirogloso).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">2.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">TIROIDITIS<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Inflamación
del
        tejido tiroideo. Hay 4 tipos:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l15 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">TIROIDITIS
          DE HASHIMOTO: <o:p></o:p></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Etiología</u>:
        autoinmune, frecuente en mujeres.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level3 lfo3"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Ac</u>:
        en la mayoría hay anticuerpos antiperoxidasa tiroidea en suero.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Clínica</u>:
        suele cursar con hipotiroidismo (y a veces bocio), pero no esta
        indicada la
        cirugía si el bocio no es compresivo.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Macro</u>:
        el tiroides es grisáceo, con muchos nódulos, consistencia blanda
        (recuerda a un
        ganglio linfático).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Micro</u>:
        destrucción de folículos tiroideos (sustituidos por tejido
        linfoide maduro, con
        muchos folículos linfoides con centro germinativo y periferia
        con células
        plasmáticas). Transformación oncocítica del epitelio de los
        folículos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l15 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">TIROIDITIS
          SUBAGUDA LINFOCITARIA INDOLORA:<o:p></o:p></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Etiología</u>:
        autoinmune, frecuente en mujeres tras el parto, y adultos de
        edad media.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level3 lfo3"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Ac</u>:
        anticuerpos antitiroideos (por lo que se considera variante de
        Hashimoto).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Clínica</u>:
        tumefacción no dolorosa del tiroides, e hipertiroidismo (<span
          style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">≠</span>
        Hashimoto).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Micro</u>:
        destrucción folicular focal con infiltrados linfocitarios.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Evolución</u>:
        en la mayoría cura (no progresa a tiroiditis crónica); 1/3 de
        los pacientes
        evolucionan a hipotiroidismo.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l15 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">TIROIDITIS
          AGUDA GRANULOMATOSA DE QUERVAIN:<o:p></o:p></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Etiología</u>:
        viral (suele precederse de una infección respiratoria, mujeres
        de edad media.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Clínica</u>:
        tumefacción dolorosa (en parte anterior del cuello), fiebre,
        astenia, mialgias.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Micro</u>:
        destrucción del epitelio folicular, rodeado primero de PMN y
        luego de
        macrófagos y CGM, formando granulomas alrededor de los folículos
        destruidos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Evolución</u>:
        cura en un par de meses.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l15 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">TIROIDITIS
          DE RIEDEL:<o:p></o:p></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Etiología</u>:
        inflamación crónica fibrosante del tiroides de etiología
        desconocida (sugiere
        relación con una proliferación fibromatosa del tejido
        conjuntivo, ya que esa
        fibrosis ocurre en otros tejidos). Típico de adultos (más
        frecuente en mujeres)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Clínica</u>:
        masa dura, no dolorosa, en zona tiroidea (en casos avanzados,
        hipotiroidismo).
        Si la inflamación crónica fibrosante se extiende, provoca
        disfagia, disfonía y
        disnea.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Macro</u>:
        tiroides aumentado de tamaño y fibroso, muy adherido a tejidos
        adyacentes.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l15
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Micro</u>:
        destrucción de folículos tiroideos (sustituidos por tejido
        fibroso denso).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <table class="MsoTableGrid"
        style="border-collapse:collapse;border:none;mso-border-alt:solid
        windowtext .5pt; mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt
        0cm 5.4pt" cellspacing="0" cellpadding="0" border="1">
        <tbody>
          <tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes">
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">HASHIMOTO<o:p></o:p></b></p>
            </td>
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              border-left:none;mso-border-left-alt:solid windowtext
              .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm
              5.4pt 0cm 5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">SUBAGUDA
                  LINFOCIT.<o:p></o:p></b></p>
            </td>
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              border-left:none;mso-border-left-alt:solid windowtext
              .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm
              5.4pt 0cm 5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">AGUDA
                  GRANULOMT.<o:p></o:p></b></p>
            </td>
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              border-left:none;mso-border-left-alt:solid windowtext
              .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm
              5.4pt 0cm 5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">RIEDEL<o:p></o:p></b></p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:1">
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Autoinmune: Ac antipx.</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Autoinmune: Ac antitir.</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Viral (tras infecc)</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Desconocida (fibrosa)</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:2">
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Mujeres 7:1</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Mujeres postparto</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Mujeres EM</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Adultos (&gt;mujeres 4:1)</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:3">
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Hipotiroidismo (bocio)</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">NO DOLOR. Hiper&gt;Hipo</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">SI DOLOR</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">NO DOLOR (hipo)</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:4;mso-yfti-lastrow:yes">
            <td style="width:132.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Destrucción = TEJIDO LINFOIDE</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Destrucción folículos = INFILTRADO LINF.</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Destrucción epitelio = GRANULOMAS</p>
            </td>
            <td style="width:132.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="133" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center">Destrucción = TEJIDO FIBROSO DENSO</p>
            </td>
          </tr>
        </tbody>
      </table>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">3.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">ENFERMEDAD
            DE GRAVES<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Hiperplasia
difusa
        del tiroides, afecta a adultos jóvenes (más a hombres 5:1).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l16 level1 lfo4"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>:
        hipertiroidismo, oftalmopatía
        infiltrativa (exoftalmos y retracción palpebral) y dermatopatía
        infiltrativa
        (mixedema pretibial). Suele provocar también bocio.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l16 level1 lfo4"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>:
        autoinmune, por deficiente
        función de L<sub>T</sub> supresores (permiten proliferación
        excesiva de L<sub>Th</sub>,
        estimulando a linfocitos B, que producen Ac, que provocan:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Al
unirse
        a las células foliculares, estimulan su función y el crecimiento
        tiroideo.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Al
unirse
        a fibroblastos perioculares, provocan que sinteticen colágeno,
        provocando retracción palpebral.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Facilitan
acumulo
        de MPS retroorbitarios, facilitando la protrusión ocular
        (exoftalmos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l16 level1 lfo4"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>:
        tiroides grande y de
        consistencia aumentada, y color pálido. Los folículos tienen:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Epitelio
hiperplásico
        y células altas de núcleos pseudoestratificados.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Coloide
pálido
        con vacuolas de tipo reabsortivo.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l16
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Puede
haber
        infiltrado linfoplasmocitario en el intersticio interfolicular y
        en
        tejidos perioculares.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">4.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">CARCINOMA
            PAPILAR DE
            TIROIDES<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Tumor
        epitelial maligno, derivado del epitelio folicular. Es el más
        frecuente (75% de
        neoplasias de tiroides). Afecta a adultos (30-40 años), más a
        mujeres 3:1, y se
        asocian a radiaciones ionizantes.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="margin-left:18.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level1 lfo5"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: podemos
        detectar:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Solo
el
        nódulo tiroideo (carcinoma)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Nódulo
tiroideo
        + ganglio cervical aumentado (por metástasis linfática)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Solo
el
        ganglio metastásico cervical (sin palpar lesión en el tiroides)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:18.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level1 lfo5"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Macro</u>: puede ser
        nodular, quístico,
        esclerosante focal o esclerosante difuso.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:18.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level1 lfo5"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Micro</u>: </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Las
células
        tienen sus NUCLEOS EN VIDRIO ESMERILADO: irregulares, con una
        membrana
        nítida y contenido claro (aspecto esmerilado), con
        pseudoinclusiones en su
        interior.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Presencia
de
        cuerpos de psammoma (concreciones calcáreas concéntricas).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Al
ser
        PAPILAR, las células se disponen formando papilas (estructuras
        digitiformes
        con un eje conjuntivo central y capas de células epiteliales
        alrededor).
        VARIANTES:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:90.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level3 lfo5"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->FOLICULAR:
las
        células se disponen formando folículos de aspecto oncocítico
        (‘carcinoma
        papilar con patrón folicular o folicular oncocítico’). Mejor
        pronostico.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:90.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level3 lfo5"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->ESCLEROSANTE:
además
        de áreas papilares y solidas, hay intensa reacción desmoplástica
        que
        afecta a la glándula tiroidea. Asociado a metástasis
        ganglionares.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:90.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level3 lfo5"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->MICROPAPILAR:
papilas
        muy pequeñas (&lt;1cm) detectadas en el estudio de tiroides
        extirpado
        por otras patologías (Graves, Hashimoto…).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:18.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level1 lfo5"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Evolución</u>: se
        clasifican en estadios:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Estadio
I:
        tumor solo en tiroides (supervivencia a 5 años: 98%).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Estadio
II:
        metástasis ganglionares en ganglios del cuello (supervivencia
        98%: no
        empeora el pronostico). Como hemos visto, a veces las metástasis
        son la primera
        manifestación.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Estadio
III:
        infiltra tejidos blandos del cuello (supervivencia 70%).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:54.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l6
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Estadio
IV:
        metástasis hematógenas a distancia (la supervivencia cae).</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:18.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l6
        level1 lfo5"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Tratamiento</u>:
        quirúrgico (tiroidectomía
        total), ya que muchas veces el tumor es multicéntrico.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><span
          style="font-family:Webdings">ii</span> No confundir el
        carcinoma papilar con
        patrón folicular, con el carcinoma folicular de tiroides.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l12 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">5.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">CARCINOMA
            FOLICULAR DE
            TIROIDES<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Carcinoma
de
        tiroides poco frecuentes (no más de 15-20%). Forma folículos,
        pero el núcleo
        de sus células no es en vidrio esmerilado como en el carcinoma
        papilar.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l9 level1 lfo6"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Para el diagnostico se
        requieren criterios
        histológicos: invasión de la capsula y/o presencia de permeación
        neoplásica
        intravascular.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo6"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Macro: hay dos variantes:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9
        level2 lfo6"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Mínimamente
invasivo:
        igual que un adenoma folicular, pero además hay invasión de la
        capsula o vasos de la capsula (o ambos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9
        level2 lfo6"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Ampliamente
invasivo:
        la neoplasia penetra en el tejido tiroideo adyacente.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo6"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Micro: tumor formado por
        folículos (parecido al
        adenoma folicular), pero al buscar minuciosamente, encontramos
        que la capsula
        de tejido conjuntivo que le rodea está rebasada, o bien que
        nidos de folículos
        están en la luz de vasos de la capsula.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo6"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Suele diseminar vía
        hemática (metástasis a
        hígado, pulmón y hueso). Supervivencia del 70% en el mínimamente
        invasivo, y
        sólo un 30% en el ampliamente invasivo.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l9 level1 lfo6"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Tratamiento: quirúrgico
        (extirpación del
        hemitiroides + I<sup>131</sup>).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l12 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">6.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">TUMOR DE
            CÉLULAS DE HÜRTLE<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Tumor
        tiroideo formado por oncocitos (células de citoplasma amplio,
        acidófilo y
        granular que contienen gran cantidad de megamitocondrias), que
        puede
        corresponder a un carcinoma papilar o folicular:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l5 level1 lfo7"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Primero, fijarnos en los
        <u>núcleos</u> de las
        células:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level2 lfo7"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Si
son
        en vidrio esmerilado: <i style="mso-bidi-font-style:normal">carcinoma
papilar
          de células de Hürtle</i>.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level2 lfo7"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Si
no,
        valorar <u>criterios de infiltración</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level3 lfo7"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Si
infiltra
        capsula o vasos capsulares: <i
          style="mso-bidi-font-style:normal">carcinoma
          folicular de células de Hürtle</i>.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level3 lfo7"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Si
no
        infiltra: <i style="mso-bidi-font-style:normal">adenoma de
          células de Hürtle</i>.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l12 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">7.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">CARCINOMA
            MEDULAR DE TIROIDES<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Tumor
        tiroideo derivado de las células parafoliculares (secretoras de
        calcitonina).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l5 level1 lfo7"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Puede ser esporádico o
        familiar (20% de los
        casos, autosómico dominante).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level2 lfo7"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Si
es
        familiar, puede ser solitario o asociado a una NEM (NEM-2a o
        NEM-2b).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level2 lfo7"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->En
las
        formas familiares hay mutación del oncogén ret, lo que se usa
        para su
        diagnostico y para screening familiar.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l5 level1 lfo7"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Macro: tumor único (o
        múltiple en formas
        familiares), blanquecino, de consistencia firme pero mal
        delimitado al
        parénquima adyacente.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l5 level1 lfo7"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Micro: formado por
        celulas poligonales, de
        aspecto inocente, sin atipias ni mitosis.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level2 lfo7"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Inmunohistoquímica:
positividad
        para cromogranina y calcitonina.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l5
        level2 lfo7"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->En
el
        estroma tumoral hay depósitos de sustancia amiloide derivados de
        péptidos
        modificados de calcitonina.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l5 level1 lfo7"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->La neoplasia infiltra
        estructuras del cuello, y
        da metástasis linfáticas y hemáticas.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 28<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l8
        level1 lfo8"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">SÍNDROME
            DE CUSHING<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Síndrome
        con hiperfunción cortical con hipersecreción de cortisol.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l7 level1 lfo9"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Clínica: cara de luna
        llena con obesidad troncular;
        atrofia cutánea y muscular con osteoporosis, debilidad,
        hirsutismo,
        intolerancia a la glucosa, encefalopatía, inmunodepresión e
        infecciones.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l7 level1 lfo9"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->AP: la morfología de la
        corteza suprarrenal
        varía según la etiología:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Iatrogénica</u></i>
        (administración
        prolongada de corticoides): atrofia bilateral.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Adenoma basófilo o
            hiperplasia
            hipofisaria</u></i>: hiperplasia bilateral.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Secreción ectópica de
            ACTH</u></i>:
        hiperplasia</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Lesión cortical</u></i>:
        hiperplasia,
        adenoma o carcinoma unilateral. Si es funcionante, hay atrofia
        contralateral (puede
        no ser funcionante).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Hiperplasia
          cortical</u>: hiperplasia bilateral y secundaria a un aumento
        de ACTH.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Hay aumento de las capas
        reticular y
        fasciculada, con engrosamiento difuso de la corteza.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Variante: hiperplasia
        micronodular pigmentada
        (en niños, no relacionada con ACTH; células con pigmentos tipo
        melanina).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Adenoma
          cortical</u>: tumor único, bien definido, amarillento. Corteza
        adyacente y
        contralateral atróficas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Formado por células
        grandes, microvacuoladas,
        sin atipias ni mitosis.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Carcinoma
          cortical</u>: tumor grande, no encapsulado, infiltra el
        retroperitoneo.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Células grandes, con
        altas atipias y mitosis. </p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Hay áreas de necrosis y
        hemorragia.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l8 level1 lfo8"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">2.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">HIPERALDOSTERONISMO<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Primario:
      </p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l0 level1 lfo10"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->70% Adenoma cortical con
        hipersecreción de
        aldosterona (síndrome de Conn). Los adenomas son tumores
        pequeños, solitarios,
        y sus celulas se parecen a las de la capa fasciculada cortical.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l0 level1 lfo10"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->30% Hiperplasia cortical.
        El carcinoma secretor
        de aldosterona es muy poco frecuente.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Secundario:
por
        activación del sistema renina-angiotensina, que se produce por:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l13 level1 lfo11"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Isquemia renal, o estados
        de edema crónico.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l13 level1 lfo11"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Tumores productores de
        reninaToma de
        anticonceptivos, diabetes insípida y síndrome de Bartier
        (hiperplasia de
        celulas del aparato yuxtaglomerular).</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l13 level1 lfo11"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->En el hiperaldosteronismo
        secundario la morfología
        de las suprarrenales suele ser normal.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l8
        level1 lfo8"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">3.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">SISTEMA
            SIMPÁTICO-ADRENAL<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Es
        un sistema neuroendocrino que se encarga de la secreción de
        catecolaminas para
        actuar en zonas desinervadas de forma duradera. Derivan de las
        células
        primitivas de la cresta neural, dando:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l4 level1 lfo12"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->M2: se quedan en los
        ganglios simpáticos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l4 level1 lfo12"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->M1: maduran a neuronas
        (dando neuroblastomas)</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l4 level1 lfo12"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->M3: maduran a células
        cromafines (dando
        feocromocitomas).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Está
        formado por:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l1 level1 lfo13"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Sistema nervioso
        simpático</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l1 level1 lfo13"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Medula suprarrenal: parte
        central de la glándula,
        formada por células cromafines (ya que se tiñen de color pardo
        con la reacción
        cromafín, lo que evidencia que hay catecolaminas) y una red
        vascular capilar
        alrededor. </p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l1 level1 lfo13"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Paraganglios cromafines:
        situados a ambos lados
        de la columna, crecen hasta los 3 años y luego involucionan.
        Formador por
        células cromafines y células ganglionares. </p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Las
        neoplasias más frecuentes dependen de la edad:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l11 level1 lfo14"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Infancia: estirpe neural
        (neuroblastoma,
        ganglioneuroblastoma y ganglioneuroma)</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l11 level1 lfo14"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Adulto: células
        cromafines (hiperplasia medular
        suprarrenal y feocromocitoma).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l3 level1 lfo15"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>TUMORES
            NEURALES</u></i>: son los 4º tumores más frecuentes en
        niños. Pueden situarse
        en cualquier parte del SNS, pero sobre todo en abdomen
        (suprarrenal y ganglios
        paravertebrales). Micro: blancos, voluminosos, blandos con áreas
        de hemorragia,
        necrosis y calcificación.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level2 lfo15"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>NEUROBLASTOMA</u>:
        tumor muy indiferenciado, en que las células están alrededor de
        un espacio
        central claro, formando SEUDORROSETAS DE HOMER-WRIGHT (formadas
        de
        prolongaciones fibrilares de las células). Hay distintos
        factores pronósticos:</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <table class="MsoTableGrid"
        style="border-collapse:collapse;border:none;mso-border-alt:solid
        windowtext .5pt; mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt
        0cm 5.4pt" cellspacing="0" cellpadding="0" border="1">
        <tbody>
          <tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">FAVORABLE</p>
            </td>
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-left:none;mso-border-left-alt:solid windowtext
              .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">DESFAVORABLE</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:1;mso-yfti-lastrow:yes">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Edad

                &lt;18 meses</p>
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Tumor

                localizado (sin metástasis)</p>
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Diferenciación

                a ganglioneuroma/céls. Schwann</p>
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">No

                alteraciones cromosómicas/telomerasas</p>
            </td>
            <td style="width:265.0pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Edad

                &gt;18 meses</p>
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Tumor

                no resecable, metástasis (gangl/linf)</p>
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">No

                células ganglionares ni céls. Schwann</p>
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Alteraciones

                cromosómicas</p>
            </td>
          </tr>
        </tbody>
      </table>
      <p class="MsoListParagraphCxSpFirst"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level2 lfo15"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>GANGLIONEUROBLASTOMAS</u>:
        tumores neuronales con diferenciación a células ganglionares
        (núcleo mas
        grande, y sustancia de Nissl = gránulos basófilos en
        citoplasma). También
        aparecen células de Schwann.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level3 lfo15"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Grado
histológico:
        depende de:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level4 lfo15"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Capacidad de los
        neuroblastos primitivos para
        diferenciarse en células ganglionares.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level4 lfo15"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Cantidad de material
        eosinófilo neurofibrilar </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level3 lfo15"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Los
neuroblastomas
        y ganglioneuroblastomas pueden madurar o sufrir regresión
        espontanea.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l3
        level2 lfo15"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>GANGLIONEUROMA</u>:
        tumor benigno poco frecuente, típico de niños. Son bien
        delimitados y
        blanquecinos, formados por células ganglionares y células de
        Schwann (lo aunque
        hay zonas sin células ganglionares que pueden confundirse con un
        neurofibroma).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l3 level1 lfo15"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>TUMORES
            DE CÉLULAS CROMAFINES</u></i>: tienen excesiva producción de
        catecolaminas,
        puede ser continua (dan HTA mantenida) o discontinua (HTA
        paroxística).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level2 lfo15"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>HIPERPLASIA
MEDULAR
          SUPRARRENAL</u>: hablamos de ella cuando la glándula es
        macroscópicamente
        normal, pero con aumento de tamaño (difuso o nodular).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level3 lfo15"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Cuando
la
        hiperplasia es multinodular hay que hacer DD con el
        feocromocitoma, según el
        tamaño: &lt;1cm diámetro hiperplasia medular; &gt;1cm
        feocromocitoma.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level2 lfo15"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>FEOCROMOCITOMA</u>:
        paraganglioma (ya que sus células son afines al dicromato, y
        también a la
        reacción cromafín). Pueden ser esporádicos o familiares (NEM,
        etc.).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level3 lfo15"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Tumor
del
        10%: el 10% son extrasuprarrenales, bilaterales, malignos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level3 lfo15"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Macro:
bien
        delimitado, encapsulado con gran vascularización. Si es grande,
        tiene
        degeneración isquémica (necrosis, hemorragia) en el centro.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level3 lfo15"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Micro:
células
        son eosinófilas, con muchos capilares alrededor. Pueden tener:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level4 lfo15"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Pseudoinclusiones
        celulares y glóbulos hialinos
        intracitoplasmáticos (PAS+ y diastasa resistentes).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level4 lfo15"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Abundantes vacuolas
        lipídicas degenerativas que
        simulan tumores corticales (hay que hacer inmunohistoquímica con
        enolasa
        neuronal especifica y cromogranina para diferenciarlos).</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l3
        level3 lfo15"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Hay
distinto
        grado de atipia, y no suele haber mitosis. Aun así, el grado de
        atipia
        no es predictivo del comportamiento biológico. Los únicos
        criterios seguros de
        malignidad son las metástasis.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l8
        level1 lfo8"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">4.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">PÁNCREAS
            ENDOCRINO<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">El
        páncreas endocrino está formado por los islotes de Langerhans,
        que contiene
        distintos tipos celulares que se identifican con
        inmunohistoquímica (células
        beta, alfa, delta…). Los tumores derivados de ellos cursan con
        producción de
        hormonas y se asocian a otros tumores endocrinos. Pueden ser
        adenomas y
        carcinomas, pero la hiperplasia de islotes provoca una clínica
        parecida.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l10 level1 lfo16"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>ADENOMA</u>: tumor
        bien delimitado, blando y
        rojizo (muy vascularizado).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo16"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Micro:
cordones
        y lóbulos de células epiteliales con estroma muy vascularizado
        alrededor. Secretan hormonas (demostrables por
        inmunohistoquímica): pueden ser
        insulinomas, glucagonomas, gastrinomas…</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo16"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Clínica:
puede
        ser por:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level3 lfo16"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Compresión:
del
        drenaje pancreático o de estructuras vecinas (colon).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level3 lfo16"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Secreción
de
        hormonas, dando:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo16"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Hiperinsulinismo (da
        crisis hipoglucémicas con
        trastornos psíquicos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo16"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Síndrome de
        Zollinger-Ellison: ulceras por
        hipersecreción de gastrina.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo16"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->NEM-I: con lesiones
        hipofisarias, paratiroideas
        e islotes. Dan hiperparatiroidismo.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo16"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Otros cuadros por
        producción de glucagón, VIP
        (diarrea con hipopotasemia), somatostatina, serotonina…</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l10 level1 lfo16"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>HIPERPLASIA DE ISLOTES</u>:
        hay dos tipos:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo16"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->DIFUSA:
presencia
        de islotes gigantes en recién nacidos hijos de diabéticas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo16"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->NODULAR:
presencia
        de nódulos similares a adenomas (debe de haber solo uno, si hay
        varios
        no se trataría de adenomas sino de hiperplasia adenomatosa).</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l10 level1 lfo16"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>CARCINOMA</u>: solo se
        distingue del adenoma
        por la presencia de metástasis.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l8
        level1 lfo8"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">5.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">NEOPLASIAS
            ENDOCRINAS
            MÚLTIPLES (NEM)<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Grupo
        de síndromes familiares (con herencia dominante) que pueden
        afectar a la vez a
        varios órganos endocrinos. Hay distintos tipos:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l2 level1 lfo17"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol;mso-ansi-language:EN-US" lang="EN-US"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><u><span
            style="mso-ansi-language:EN-US" lang="EN-US">NEM-I (SÍNDROME
            DE WERMER)<o:p></o:p></span></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Poco
frecuente,
        por mutación del gen supresor MEN-1.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Afecta
a
        3 glándulas: <i style="mso-bidi-font-style:normal">paratiroides</i>
        (adenoma
        o hiperplasia), <i style="mso-bidi-font-style:normal">hipófisis</i>
        (adenoma o
        hiperplasia, frecuentemente prolactinoma) e <i
          style="mso-bidi-font-style:normal">islotes
          de Langerhans</i> (adenoma, hiperplasia o carcinoma). Ademas,
        suele asociar
        hiperplasia de corteza suprarrenal.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Clínica:
alteraciones
        hormonales diversas, pero siempre da hiperparatiroidismo.
        También
        puede comprimir o dar clínica hormonal (glucagón, VIP,
        somatostatina…).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Las
hiperplasias
        suelen ser nodulares (con nódulos múltiples), siendo
        hiperplasias
        adenomatosas (ya que los adenomas son únicos). </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo17"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>NEM-IIa (SÍNDROME DE
          SIPPLE)<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Por
mutación
        del protooncogen ret del cromosoma 10, en la línea germinal.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Produce
        <i style="mso-bidi-font-style:normal">feocromocitoma,
          hiperplasia paratiroidea
          y carcinoma medular de tiroides</i> (que se asocia a
        hiperplasia de células C
        secretoras de calcitonina).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Dx:
hacer
        estudio genético familiar (protooncogen RET), estudio de
        calcitonina
        (aumentado en familiares afectos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->El
carcinoma
        tiroideo suele ser multicéntrico, el feocromocitoma bilateral, y
        el
        paratiroides suele producir hiperparatiroidismo.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo17"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>NEM-IIb:<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Por
mutación
        del protooncogen RET del cromosoma 10, pero distinta a NEM-IIa.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l2
        level2 lfo17"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Igual
que
        NEM-IIa, pero <i style="mso-bidi-font-style:normal">sin
          hiperparatiroidismo</i>
        y <i style="mso-bidi-font-style:normal">con ganglioneuromas
          mucocutáneos</i> y <i style="mso-bidi-font-style:normal">habito
          marfanoide</i>.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
    </div>
  </body>
</html>
